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Abstract Robotic pelvic lymphadenectomy is a well
established procedure in the urologic and gynecologic
literature. To our knowledge robotic pelvic lymphadec-
tomy for metastatic melanoma has yet to be described.
Herein we present the ﬁrst report of robot-assisted pelvic
lymphadenectomy in malignant melanoma. After place-
ment of six laparoscopic ports (12 mm camera, three
8-mm robotic ports, 12-mm and 5-mm assistant ports) the
DaVinci S robot (Intuitive Surgical, CA, USA) was
docked in standard fashion with the patient in low
lithotomy. In both cases the patients had enlarged pelvic
lymph nodes on computed tomography and complete
excision of these masses was accomplished along with
complete lymphadenectomy extending from Cooper’s
ligament to just below the hypogastric artery in case 1
and to level of the bifurcation of aorta in case 2. A PK
Maryland Dissector and monopolar scissors were used for
dissection. Both patients were discharged on postoperative
day #1. Robotic pelvic lymphadenectomy can be safely
used for management of patients with metastatic mela-
noma involving the pelvic lymph nodes. Compared with
the standard open procedure, pelvic lymphadenectomy
with robotic assistance is associated with excellent vision
and minimum morbidity.
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Introduction
Cutaneous melanoma is traditionally managed with wide
local excision down to the deep fascia [1]. For higher-risk
lesions based on pathologic features including Clark and
Breslow criteria, lymphatic mapping with sentinel lymph
node biopsy is performed to detect regional nodal disease
and determine the need for more aggressive lymphade-
nectomy. In the groin this may include superﬁcial and
deep inguinal lymph node dissection [2]. Pelvic node
dissection for melanoma and other malignancies (i.e.
prostate, bladder, penis) has been accomplished via an
open and laparoscopic route [3]. In addition, in some
cases, limited sites of distant metastatic disease occur
which may be amenable to surgical excision for curative
purposes or prevention of morbidity from local tumor
invasion [4–6]. Herein we present the ﬁrst report, to our
knowledge, of two cases of RPL and excision of isolated
pelvic melanoma metastases.
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Case 1
The patient is a 50-year-old man who ﬁrst presented in
2006 with a changing pigmented lesion on his right upper
medial calf below the knee. On biopsy, this lesion was
found to be a 16-mm Clark level V melanoma with focal
ulceration and a high mitotic rate. The patient presented
with palpable right inguinal lymph nodes. A ﬁne needle
aspirate showed only reactive lymphocytes. Metastatic
work-up included full body PET/CT scan and MRI of the
brain which showed no evidence of metastatic disease. A
wide local excision of the lesion with 2-cm margins and
sentinel lymph node biopsy was performed. Pathology
showed malignant melanoma measuring 2-mm in greatest
diameter with negative surgical margins and lymph nodes.
Subsequently, the patient presented eleven months later
with a mass on the superior aspect of the surgical excision
site, and a palpable inguinal lymph node. Fine needle
aspirate of the palpable node was positive for malignant
melanoma. The patient underwent a wide local excision of
the recurrent lesion, and open right inguinal lymph node
dissection. Pathology again showed malignant melanoma,
with clear proximal and distal margins, and 20 of 20 nodes
positive for metastatic melanoma. He was started on sys-
temic therapy with G-CSF for ﬁve months. PET/CT scan
showed a 4.2 cm, right iliac nodal mass with central
necrosis. The decision was made to pursue RPL and
metastasectomy.
Case 2
A 53-year-old women initially underwent a wide local
excision of a 5.5 9 4.0 cm melanoma over the left ﬁbular
head in 2002 with hemigastrocnemius muscle ﬂap and split
thickness skin graft from the buttock for coverage. Con-
current with this procedure, Lymphazurin injection and
gamma probe excision of three superﬁcial inguinal sentinel
lymph nodes showed counts of 1,700 per second. Pathol-
ogy revealed nodular type malignant melanoma (Clark V,
Breslow 19 mm) with negative margins; 1 of 3 lymph
nodes were positive for micrometastatic disease. Given a
negative metastatic work-up and consultation with hema-
tology–oncology the patient elected at that time for no
further treatment. In 2007, she recurred approximately
10 cm distant from the initial lesion. Metastatic work-up
with a PET scan was negative. Lymphoscintigraphy was
performed with 1 mCi of ﬁltered technetium 99 m sulfur
colloid which identiﬁed migration of radioactivity to two
left inguinal lymph nodes. She underwent repeat wide local
excision and sentinel lymph node mapping with counts in
excess of 15,000 per second in the region of the inguinal
ligament. The primary lesion again was malignant mela-
noma (Clark V and Breslow 3 mm) with negative margins
and 4 of 8 nodes involved with disease. She again declined
any further adjuvant therapy. In 2008, she was found to
have a 5.0 9 3.0 cm left external iliac lymph node on CT
scan and underwent CT-guided biopsy of left obturator
chain lymph node revealing metastatic melanoma. A robot-
assisted laparoscopic left pelvic lymph node dissection
with metastasectomy and deep inguinal groin dissection
were performed.
Methods
Between January 2007 and July 2008 two patients under-
went robotic excision of metastatic melanoma with pelvic
lymphadenectomy. After Institutional Review Board
approval (exemption), the medical records were reviewed
for clinical, operative, and pathologic data.
Technique
The patients were placed on spreader bars in exaggerated
Trendelenburg position. A Foley catheter was placed.
Pneumoperitoneum to 20 mm Hg was established with
closed Veress needle insertion just above the umbilicus. A
12-mm port was placed above the umbilicus, two 8-mm
robotic ports were placed lust lateral to the medial umbil-
ical ligaments approximately 16 cm from the pubic sym-
physis and 10 cm from the midline. A third 8-mm robotic
port was placed for the fourth robotic arm on the left side
10 cm lateral to the left sided 8-mm robotic port. A 12-mm
assistant port was placed in the right lower quadrant and a
5-mm port in the right upper quadrant two ﬁnger breadths
below the costal margin 2 cm medial to the 8 mm port
(Fig. 1). The DaVinci S robot was docked and pneumo-
peritoneum was lowered to 12 mm Hg.
Case 1
The ureter was identiﬁed as it crossed-over the external
iliac artery and the posterior peritoneum was incised lateral
to this and medial to the artery. The ureter was mobilized
and the mass was identiﬁed inferomedially. The mass was
adherent to the external iliac vein and extended down on to
the obturator nerve (Fig. 2). The medial border of the
external iliac vein was exposed. The external iliac vein was
retracted laterally with a 10 mm Kitner and the mass was
circumscribed and separated from the vein using mono-
polar cautery, argon beam coagulation, and 5 mm clips.
The vas deferens was identiﬁed and transected using
bipolar cautery to improve access to the iliac-obturator
nodes. The obturator nerve was identiﬁed and separated
130 J Robotic Surg (2010) 4:129–132
123from the mass. The tissue from the obturator fossa up to the
common iliac artery was removed. The obturator lymph
node tissue and mass were removed en bloc and placed in a
10 mm Endocatch bag (Covidien, CA, USA). After copi-
ous irrigation with sterile water and observation for
hemostasis under 2 mm Hg pneumoperitoneum, Floseal
(Baxter, CA, USA) and Surgicel (Ethicon, NJ, USA) were
placed along the resection bed and the specimen was
removed through the supraumbilical port site after
extending the incision to 3 cm.
Satisfactory pain control was achieved with 30 mg IV
Toradol every 6 h and Tylenol. The patient was discharged
home on postoperative day #1 in good condition with
minimal pain. At one week follow-up the incisions were
healing well and the patient was tolerating light physical
activity with no narcotics.
Case 2
Adhesions were taken down from the colon and the line of
Toldt was incised sharply and then the colon was reﬂected
medially. The external iliac artery was identiﬁed and the
lymph node packet between the artery and the vein was
dissected up to the bifurcation of the common iliac artery.
The mass in the obturator fossa (Fig. 3) was identiﬁed and
dissected out using monopolar and bipolar cautery and
5 mm clips. The obturator nerve was identiﬁed and pre-
served. The packets were placed in 10 mm Endocatch
bags. After observation for bleeding under 2 mm Hg
pneumoperitoneum, Floseal was placed in the dissection
bed and the specimens were removed through the midline
port site after extending the incision slightly. Immediately
following this procedure she underwent a deep inguinal
lymphadenectomy including removal of the saphenous
vein. Final pathology from the groin dissection revealed
3/3 positive nodes, 4/15 positive nodes from the external
iliac artery, and obturator lymph node chains.
On postoperative day 1 the patient was discharged home
tolerating a regular diet with pain well controlled by Tor-
adol and Vicodin. On one week follow-up the surgical
incisions were healing well and she was tolerating light
physical activity. She currently is undergoing evaluation
for adjuvant therapy.
Discussion
Although the role of pelvic lymphadenectomy is well
established in the management of urologic and gynecologic
malignancies, its role in staging and management of
malignant melanoma continues to evolve. Contemporary
indications for deep pelvic lymphadenectomy include:
1 four or more positive superﬁcial lymph nodes;
2 radiological imaging or clinico-pathological evidence
of deep pelvic node involvement; or
3 conﬁrmed metastatic disease within the node of
Cloquet [7].
Fig. 1 Schematic diagram of port placement
Fig. 2 Contrast enhanced CT
of the pelvis showing right
obturator mass (arrow) in axial
(a) and coronal planes (b)
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patients who underwent deep pelvic lymph node dissection,
the presence of three or fewer positive deep pelvic lymph
nodes was associated with increased cancer-speciﬁc sur-
vival over ﬁve years.
For any procedure, particularly for staging purposes, the
risk beneﬁt analysis is critical. Much of the morbidity of
traditional open pelvic lymphadenectomy is due to inci-
sional complications. Standard laparoscopy was introduced
in an effort to reduce this morbidity [8]. The advantages of
a minimally invasive approach in pelvic lymph node dis-
section have been well documented in the literature and
include accelerated healing time, shortened postoperative
disability period, less incisional pain, and reduced scarring
[9].
Although the beneﬁts of laparoscopic lymphadenectomy
have been established, the technical challenges, particu-
larly in cases with enlarged metastatic lymph nodes, have
limited its widespread application. The introduction of a
robotic interface has shortened the learning curve and
dramatically expanded the acceptance of complex, less
invasive (laparoscopic) surgical procedures [10]. The
beneﬁt of robot assistance for radical prostatectomy with
pelvic lymph node dissection has been widely described in
the literature [11]. The magniﬁcation that the robot enables
and the 3D visual capacity aid in meticulous dissection of
the tissue, which may increase nodal yield and reduce
operative morbidity. Robot assistance incorporates the
minimally invasive beneﬁts of classic laparoscopy with the
additional beneﬁts of increased visualization and dexterity.
Conclusions
RPL for metastatic melanoma can be performed safely.
The exact role of RPL in malignant melanoma remains to
be determined. This initial report supports further study
into the application of robotics to the management of
metastatic melanoma in the pelvis.
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